$TACT

TransAct Technologies Incorporated Q2 2026 Earnings Call Summary

TransAct Technologies reported Q2 2026 progress shifting its Food Service Technology segment to higher-margin recurring SaaS. Software revenue grew 47% YoY, aided by price increases and ending free bundling, and BOHA! migration to Microsoft Azure. Full-year 2026 net sales guidance is $55M to $57M, adjusted EBITDA $1.5M to $2.0M. Tariff ruling cut net sales by $1M and EBITDA by $400k.

Original reporting
Published Aug 13, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TransAct Technologies Incorporated Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$TACTBullishMed
01

Why it matters

The most tradable elements are the reaffirmed sales guidance, raised adjusted EBITDA guidance, and specific operational initiatives (Azure migration, pricing and bundling changes, and new venue reporting metrics). The gaming strategic review introduces optionality but lacks timing, which can keep valuation and risk premia elevated.

02

Market read

For TACT, the combination of higher adjusted EBITDA guidance and quantified SaaS transition mechanics (software growth, pricing, Azure migration) is likely the primary driver for near-term positioning, while the gaming review is a secondary overhang/option.

03

What to watch

The Supreme Court tariff ruling is a one-off headwind with refunds; traders may over-weight the software growth rate without validating churn, conversion-cycle timing, and the eventual outcome of the gaming business review.

Relevance 7/10Novelty 6/10Timing: after-hours earnings call summary published Aug 13, 2026

Background

This is a Q2 2026 earnings call summary focused on TransAct’s shift from hardware to recurring SaaS in its Food Service Technology segment, alongside a strategic review of its Casino and Gaming unit.

Company-level read

Ticker impact

$TACTBullishMedium confidence
Context

TransAct reaffirmed 2026 net sales guidance of $55M to $57M and raised adjusted EBITDA to $1.5M to $2.0M on its FST SaaS shift.

Expected impact

Bias modestly positive for the next few sessions as traders digest higher EBITDA guidance and recurring-software unit economics targets.

Evidence & confidence

The article contains multiple concrete management disclosures tied to TACT’s operating model (software revenue growth, EBITDA guidance, Azure migration, bundling pricing) plus a new strategic review that could affect capital allocation.

Market effects

Reinforces a broader payments/vertical-software narrative where recurring SaaS mix and cloud migration are used to justify margin expansion.

No clear regional spillover beyond US-listed small-cap software/vertical tech sentiment.

Tariff-related refund dynamics highlight cross-border policy risk, but impact is quantified as company-specific in the article.

Counterpoint

The raised EBITDA range may be offset by execution risk in the sales-team overhaul and slower net-new customer growth during the transition.

Key entities

  • TransAct Technologies Incorporated

    Subject of the earnings call summary, guiding 2026 net sales and adjusted EBITDA while transitioning BOHA! software to a recurring SaaS model.

  • BOHA! platform

    Food Service Technology software platform being migrated to Microsoft Azure to accelerate the software roadmap and integrations.

  • Casino and Gaming segment

    Profitable OEM cash-cow under formal strategic review, potentially leading to sale or capital reallocation.

  • U.S. Supreme Court tariff ruling

    Caused a quantified net sales reduction and adjusted EBITDA impact via estimated customer refunds, with partial refunds reclaimed.

Related articles

$TACTMed

TRANSACT TECHNOLOGIES INC (TACT): Results of Operations and Financial Condition

TRANSACT TECHNOLOGIES INC (TACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 TransAct Technologies Reports Preliminary Second Quarter 2026 Financial Results Sold 1,900 BOHA! Units in the Second Quarter of 2026 FST Recurring Revenue up 13% Year-over-Year Casino and Gaming Demonstrates Continued Strength Reiterates 2026 Revenue Guidance of $55

$TSLAHighAI 9/10

Tesla Posted Negative $1.1 Billion in Free Cash Flow Last Quarter as Elon Musk Ramps Up Spending on Robotaxis and Optimus. Here's Why the Company's $43.5 Billion Cash Cushion Still Matters.

Tesla reported a 26% revenue increase to $22.5B in Q2, with net income of $1.11B, but negative free cash flow of $1.1B due to $5.79B in capital expenditures. The company's $43.5B cash position provides a buffer for growth investments in robotaxis, Optimus robots, and semiconductors. Tesla's market share in U.S. EVs has risen despite industry contraction, but competition from Chinese rivals like BYD persists.

$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.

$AMZNMedAI 8/10

Should You Buy Amazon Stock For The Demand AWS Cannot Yet Serve?

Amazon.com (AMZN) stock is down 13% from its 52-week high, despite AWS's 36.7% YOY revenue growth in Q2 2026. AWS's backlog of committed contracts reached $496 billion, with demand outpacing capacity. AWS's operating margin improved 520 basis points YOY, excluding energy contract gains. Management attributes growth to AI workloads and efficient capacity use.

$ASMLMedAI 8/10

Weakness Is an Opportunity for Long-Term ASML Stock Investors

ASML's High-NA technology is gaining traction among chipmakers like Samsung, Intel, and TSMC, crucial for its long-term outlook. Q2 earnings beat estimates with €7.59 EPS and €9.33B revenue. ASML raised full-year 2026 sales guidance to €43B-€45B. Analysts have a consensus 'Hold' rating, with a mean price target of $2,350.75, implying 56% upside.